Search

Your search keyword '"SPERANZA, MARIA"' showing total 501 results

Search Constraints

Start Over You searched for: Author "SPERANZA, MARIA" Remove constraint Author: "SPERANZA, MARIA"
501 results on '"SPERANZA, MARIA"'

Search Results

1. Report: Umano post-Umano. Verso l’homo technologicus? TriesteNext 5˄ edizione 23-25 settembre 2016

3. Cassirer e la fisica einsteiniana. Il vantaggio epistemologico della teoria della relatività

4. Report: Attualità di Gabriel Tarde: sociologia, psicologia, filosofia Giornata di studi in onore di Gabriel Tarde Biblioteca di Area Umanistica dell’Università Federico II di Napoli 14 Ottobre 2015

5. FORMALITÀ E MATERIALITÀ DELL’ETICA. DAL DOVER ESSERE ALL’EVIDENZA ASSIOLOGICA

6. Report: Ordine del sentire e apertura al mondo. Filosofia delle emozioni e processo di individuazione della persona. XIII Convegno internazionale della Max‐Scheler‐Gesellschaft Università di Verona 27‐30 Maggio 2015

7. L’IMMAGINE DELL’UOMO TRA SPIRITO E NATURA. UN CONFLITTO IRRISOLTO

11. Optimization models for fair horizontal collaboration in demand-responsive transportation

15. Check List delle Briofite della Toscana

16. Check List delle Briofite dell’Emilia-Romagna. Quarta edizione

17. Check List delle Briofite della Toscana. Seconda edizione

18. Check List delle Briofite delle Marche

21. Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model

26. Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model.

28. Abstract 2990: Antigen presentation deficiency and mesenchymal differentiation underlie resistance to immunotherapy in the murine syngeneic CT2A tumor model

31. Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models

32. Figure S2 from Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma

33. Table S1 from Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma

34. Supplementary Figure 2 from Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy

35. Supplementary Data from Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy

36. Supplementary Methods and Legends from Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma

37. Supplementary Figure 1 from Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy

38. Supplementary Figure 3 from Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy

41. Inventory Routing

45. TMIC-61. LOSARTAN PREVENTS IMMUNOTHERAPY-ASSOCIATED EDEMA AND ENHANCES SURVIVAL IN GLIOBLASTOMA

47. Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma

48. Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma

Catalog

Books, media, physical & digital resources